secwatch.observer — SEC 8-K summary
======================================

Issuer:     DNA X, Inc. (SONM)
CIK:        0001178697
Form:       8-K
Filed at:   2025-04-21T23:59:59+00:00
Accession:  0001641172-25-005546
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.03, 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Sonim adopts poison pill in response to Orbic's $4.00/share takeover proposal; accelerates executive RSU vesting
--------------------------------------------------------------------------------

- Adopted limited-duration stockholder rights agreement triggered at 15.5% ownership (20% for passive investors), expiring April 21, 2026.
- Response to unsolicited Orbic North America proposal to buy outstanding shares for $4.00 per share and Orbic's rapid accumulation.
- Accelerated vesting of all previously granted RSUs for 81 employees effective April 17, 2025, including CEO Peter Liu (63,604 RSUs), CFO Clay Crolius (33,922), and CCO Charles Becher (70,671).
- Rights include flip-in, flip-over, and exchange provisions; redeemable at $0.001 per right before an acquiring person emerges.
- Board created Series A Junior Participating Preferred Stock with economic terms similar to 1,000 shares of common per preferred share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1178697/000164117225005546/0001641172-25-005546-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1178697/000164117225005546/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-005546

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer